Results 61 to 70 of about 13,744 (204)
Flecainide in clinical practice
Flecainide, similar to encainide and propafenone, is IC class antiarrhythmic, inhibiting Nav1.5 sodium channels in heart muscle cells and modulates cardiac conduction. Despite its over 40-year presence in clinical practice, strong evidence and well-known
Mikołaj Basza +14 more
doaj +1 more source
Clinical Practice Guidelines for paroxysmal supraventricular tachycardia.
Clinical Practice Guidelines for paroxysmal supraventricular tachycardia. These are arrhythmias in which structures placed above the bifurcation of the bundle of His are involved; characterized by tachycardia with abrupt starting and ending.
Brandy Viera Valdés +3 more
doaj +2 more sources
ICM arrhythmia detection and therapeutic interventions. ABSTRACT Background Insertable cardiac monitors (ICMs) provide long‐term continuous monitoring for arrhythmia diagnosis and management for various clinical indications. However, little data exists on comprehensive real‐world arrhythmia diagnostic yield and therapy rates in patients indicated for ...
Sandeep A. Saha +8 more
wiley +1 more source
Paroxysmal Supraventricular Tachycardia [PDF]
ANDRES R. TICZON, ROBERT E. WHALEN
+6 more sources
Effects of Landiolol Hydrochloride on Intractable Tachyarrhythmia After Pediatric Cardiac Surgery [PDF]
BackgroundWhile β-blockers can be effective in controlling tachyarrhythmias after pediatric cardiac surgery, a negative inotropic influence sometimes complicates their use.
Abe Masakazu +12 more
core +1 more source
Management of Ablation‐Refractory Atrial Fibrillation During Pregnancy
Development of new atrial fibrillation (AF) is uncommon in pregnancy with an incidence of 0.03%. The occurrence of drug‐refractory AF during pregnancy in individuals with structurally normal hearts is even rarer, and there are no reports of ablation‐refractory AF during pregnancy in the literature.
Faris Abu Za’nouneh +5 more
wiley +1 more source
Clinical Experience with Diltiazem in the Treatment of Cardiovascular Diseases [PDF]
Cardiovascular diseases are the leading cause of death in the world. Coronary artery diseases, atrial fibrillation or hypertensive heart disease, are among the most important cardiovascular disorders. Hypertension represents a significant risk factor for
Alejandro de la Sierra +5 more
core +4 more sources
Aims Adverse drug reactions (ADRs) are a key driver of missed doses of anti‐tuberculosis (TB) therapy. We aimed to determine the relative burden of ADR‐driven missed doses, the missed dose patterns associated with ADRs, and the association between specific ADRs and missed doses.
Eleanor G. Dixon +10 more
wiley +1 more source
Paroxysmal Supraventricular Tachycardia [PDF]
B. N. GOLDREYER, J. T. BIGGER
openaire +4 more sources
Cardiovascular Safety Landscape of ADT in Prostate Cancer Treatment Based on Real‐World Analysis
ABSTRACT Background Prostate cancer is among the most prevalent malignancies worldwide, and cardiovascular disease (CVD) is a major non‐cancer cause of death in affected patients. Androgen deprivation therapy (ADT), a mainstay treatment, has raised concerns about cardiotoxicity, yet the CVD risks of individual ADT agents remain unclear.
Wei Wang +7 more
wiley +1 more source

